UC BON.CAP.CERT. 12/25 NESR/ DE000HD6QE95 /
2024-09-05 7:46:38 PM | Chg.-1.780 | Bid8:20:22 PM | Ask8:20:22 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
98.370EUR | -1.78% | 98.400 Bid Size: 500 |
98.450 Ask Size: 500 |
Nestle S.A. | - - | 2025-12-30 | Call |
GlobeNewswire
08-13
Seres Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
08-06
Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science
GlobeNewswire
07-23
Mondelēz International Names Filippo Catalano Chief Information and Digital Officer
GlobeNewswire
06-12
NFWF Announces $10.2 Million in Grants to Cultivate Conservation Practices on Agricultural Lands
GlobeNewswire
06-06
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Sc...
GlobeNewswire
05-08
WalkMe Announces Date of First Quarter 2024 Financial Results and Conference Call
GlobeNewswire
03-26
NESTLE INTERNATIONAL AWARDED OMNIQ A PURCHASE ORDER FOR THE SUPPLY OF RUGGEDIZED IOT EQUIPMENT TO NE...
GlobeNewswire
03-19
VML Augments Digital Commerce Capabilities by Forging Partnership with CommerceIQ’s Unified Artifici...